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Antiadhesion therapy has been found to be a very promising means to
prevent and treat infections in the respiratory, urinary, and gastrointestinal tract.
Despite the considerable research interest in antiadhesives, relatively little is known
about the ability of commercial dietary oligosaccharides, such as prebiotics, to inhibit
pathogen adherence. The goal of this research was to determine if commercially
available prebiotic oligosaccharides could function as antiadhesive agents against
enteropathogenic E. coli (EPEC).
To investigate the ability of prebiotics to inhibit EPEC adherence, inhibition
assays were performed by comparing adherence rates of EPEC on HEp-2 and
Caco-2

cells

in

the

presence

of

galactooligosaccharides

fructooligosaccharides, lactulose, or raffinose.

(GOS),

inulin,

These data showed that GOS

significantly reduced binding of EPEC more than the other prebiotics tested. In
addition, binding inhibition by GOS was shown to be dose-dependent and saturable
at 16 mg/ml. Microscopic analyses indicated that GOS also reduced the number of
EPEC per microcolony and the total number of microcolonies per infected cell.

Both therapeutic and prophylactic GOS treatments were also examined.
GOS was unable to displace previously adhered EPEC, but could prevent EPEC
adherence when administered prior to infection. Additionally, GOS did not affect
EPEC autoaggregation.

To determine if GOS was inhibiting adherence at a

molecular level, the expression of BfpA, a bundle forming pili protein involved in
localized adherence, was examined. GOS did not affect BfpA expression indicating
that adherence inhibition was not due to the absence of this adhesin.
To further examine the role of EPEC adhesins in GOS-mediated adherence
inhibition, adherence assays using HEp-2 and Caco-2 cell lines were performed
using isogenic EPEC mutants. In general, GOS did not affect the adherence of
strains lacking BfpA, suggesting that GOS may interfere specifically with BfpAreceptor interactions rather than with other potential EPEC adhesins and their
receptors. These results show that commercial prebiotics, particularly GOS, directly
inhibit the adherence of E. coli, and provides evidence that these agents may be
used as antiadhesives against pathogens in both humans and animals.
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Preface
This dissertation consists of three chapters and a conclusions section.
Chapter 1 is a literature review on bacterial adherence and the mechanisms by
which adherence can be prevented. Chapter 2 describes our published (Shoaf et
al., 2006. Infect. Immun. In press) results focusing on the ability of prebiotic
oligosaccharides to inhibit the binding of enteropathogenic Escherichia coli
E2348/69 to two types of tissue culture cells. In chapter 3, we report our results on
the proposed Escherichia coli adhesins that may be involved in GOS-mediated
adherence inhibition and the direct binding of Escherichia coli E2348/69 and other
isogenic mutants to immobilized galactooligosaccharides.

Lastly, a conclusions

section summarizes the major research findings presented within this dissertation
and suggests areas for future research.

